SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-016224
Filing Date
2023-01-26
Accepted
2023-01-26 16:02:58
Documents
24
Period of Report
2023-01-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d369483d8k.htm   iXBRL 8-K 50567
2 EX-4.1 d369483dex41.htm EX-4.1 76028
3 EX-4.2 d369483dex42.htm EX-4.2 84379
4 EX-4.3 d369483dex43.htm EX-4.3 81769
5 EX-4.4 d369483dex44.htm EX-4.4 86765
6 EX-4.5 d369483dex45.htm EX-4.5 81341
7 EX-5.1 d369483dex51.htm EX-5.1 12540
8 EX-10.1 d369483dex101.htm EX-10.1 195059
9 EX-10.2 d369483dex102.htm EX-10.2 189353
10 EX-10.3 d369483dex103.htm EX-10.3 126682
11 EX-99.1 d369483dex991.htm EX-99.1 13500
15 GRAPHIC g369483dsp8.jpg GRAPHIC 5164
16 GRAPHIC g369483g0126074515647.jpg GRAPHIC 3344
  Complete submission text file 0001193125-23-016224.txt   1414376

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA ikt-20230125.xsd EX-101.SCH 2856
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE ikt-20230125_lab.xml EX-101.LAB 18737
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ikt-20230125_pre.xml EX-101.PRE 11712
18 EXTRACTED XBRL INSTANCE DOCUMENT d369483d8k_htm.xml XML 3469
Mailing Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339
Business Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 678-392-3419
Inhibikase Therapeutics, Inc. (Filer) CIK: 0001750149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39676 | Film No.: 23557679
SIC: 2836 Biological Products, (No Diagnostic Substances)